Upload
hmoresearchnetwork
View
241
Download
2
Tags:
Embed Size (px)
DESCRIPTION
Evaluating Primary Care Renewal in Oregon’s Safety Net Clinics:Preliminary Quantitative Findings Kaiser Center for
Citation preview
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Evaluating Primary Care Renewal in Oregon’s Safety Net Clinics:
Preliminary Quantitative Findings
Richard Meenan, PhD, MPH, MBA David Mosen, PhD, MPH
Sabrina Luke, MS Nancy Perrin, PhD
Work supported by AHRQ 1R18HS019146-01
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
CareOregon Non-profit Medicaid health plan HQ in Portland (1993) 155,000 low-income Oregon residents; 60% age 0-19
76% live near Portland
Network of 1,530 primary care clinicians community health centers, academic health centers, large health systems, small and
large group practices
Contracts with 6,550 specialists, 43 hospitals, 34 public health departments
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Primary Care Renewal (PCR) 2007: Transform primary care using the patient-centered
medical home (PCMH) model IHI Triple Aim: improve population health, lower cost, enhance
patient experience “Care payer” to “care integrator” Inspired by mentors at Southcentral Foundation in Alaska Internally funded financial incentive offered to clinics Plan to spread PCR to other clinics and organizations
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
PCR “Pioneer” Organizations
Virginia Garcia Memorial Health Center Federally Qualified Health Center (FQHC), Migrant
Oregon Health & Science University (OHSU) FQHC “Look-Alike”, Family Practice Residency, Urban, Ethnically Diverse
Multnomah County Health Department FQHC, Refugee, Ethnically Diverse
Legacy Health System Urban, Internal Medicine Residency
Central City Concern FQHC, Homeless, Chemical Dependencies
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Study Objectives AHRQ-funded mixed-methods PCR assessment
(quantitative and qualitative components) Our focus: Assess effect of PCR initiative on metrics
Utilization measures Hospital stays Emergency department (ED) visits Primary care visits
Cost measure Per member per month (PMPM) medical costs
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Study Population CareOregon members 1/1/06–4/30/11
Assigned to PCMH: 6 “pioneer” (2 at OHSU) and 11 “spread” clinics Assigned to non-PCMH: remaining CareOregon clinics
Segmented regression design Observation period
Pre-implementation: 1/1/06-6/30/07 (18 months) Post-implementation: 1/1/08-4/30/11 (40 months) 6-month break (7/1/07-12/31/07) for PCR implementation roll-out
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Outcome Measures and Primary Independent Variable Utilization (per 1,000 members per year)
> 1 hospital admission > 1 ED visit > 1 primary care visit
Costs: Total per member per month (PMPM) paid by CareOregon
Primary independent variable Implementation status: post- vs. pre-
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Analytic Approach: Segmented regression Clinic-month analysis (not patient-based) Models assess relative difference in slope change
from pre- to post-implementation between PCMH and non-PCMH clinics for each outcome measure
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Sample CharacteristicsPCMH Clinics Non-PCMH Clinics
Overall Population (Unique Members) 22,406 (27.1%) 60,271 (72.9%)
Demographics by Eligibility Group*Adult
Age (Mean +/- SD)Female (%)Non-white (%)Non-English language (%)
39.6 +/- 13.069.138.116.2
37.3 +/- 12.470.828.58.8
Expanded Diagnosis Cluster (EDC) Characteristics*
EDC (Mean +/- SD)% 0% 1-2% 3+
1.6 +/- 2.653.423.323.4
0.89 +/- 2.071.915.412.7
*All differences: p < .0001.
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Results: Segmented RegressionUtilization and Cost
Utilization/Cost Metric
PCMHSlope Change Post2 vs. Pre-Period1
Parameter SE
Non-PCMHSlope Change Post2 vs. Pre-Period1
Parameter SE
Interaction Term
Parameter SE
Any Hospital Utilization -5.30*** 0.96 -1.25 0.96 -4.06*** 1.37
Any ED Utilization +2.04 2.61 +1.39 2.38 +0.65 3.53
Any Primary Care Utilization
-33.30** 7.61 -18.29* 6.11 -15.01 9.76
Total Cost (PMPM)3 -10.39*** 2.00 -6.60** 1.35 -3.79* 2.41
1Pre-period includes 18 monthly time points: 1/1/2006 - 6/30/2007
2Post-period includes 40 monthly time points: 1/1/2008 - 4/30/2011
3 Cost parameters based on NON-log transformed data; p-values from log-transformed data.
*** p < .001, ** p < .05, * p < .10
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Adult Inpatient Utilization:PCMH/Non-PCMH Comparison
Adult Inpatient
0
50
100
150
200
250
300
350
Time (Month/Year)
Ra
te (
pe
r 1
00
0 a
du
lts
pe
r y
ea
r)
Non-PCMH
PCMH
Non-PCMH crude rates
PCMH crude rates
Implementation Period
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
ED Utilization:PCMH/Non-PCMH Comparison
Adult ED
0
200
400
600
800
1000
1200
1400
Time (Month/Year)
Rate
(per 1000 a
dults p
er year)
Estimated Non-PCMH
Estimated PCMH
Non-PCMH observed rates
PCMH observed ratesImplementation Period
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Primary Care Utilization: PCMH/Non-PCMH Comparison
Adult Primary Care
0
500
1000
1500
2000
2500
3000
3500
4000
Time (Month/Year)
Rate
(per 1000 a
dults p
er year)
Estimated Non-PCMH
Estimated PCMH
Non-PCMH observed rates
PCMH observed ratesImplementation Period
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
PMPM Costs: PCMH/Non-PCMH Comparison
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Preliminary ConclusionsAdult Population
Inpatient utilization
Declined at faster rate in PCMH clinics relative to non-PCMH clinics
EDutilization
No differences
Primary careutilization
No differences
PMPM costs No differences
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Limitations Analyses based on claims data only No pharmacy data available No clinical data available
For example, changes in HbA1c may be relatively more sensitive to PCMH implementation
PCR rolled out in stages, not hard implementation date More observations may be needed to assess longer-term
effects
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Policy Implications and Future Research Findings somewhat consistent with previous studies
Effect of PCMH implementation on process of care and clinical measures sensitive to change Provider payment incentives HbA1c, mental health screening, mental health functional status, etc. Access measures (e.g. same day appointment access, abandoned call rate) Continuity of care measures Satisfaction/patient experience metrics
How do challenges (and opportunities) of PCMH implementation differ between integrated health systems (e.g., GHC, Kaiser) and open “IPA-like” networks (e.g., CareOregon)?